36 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
improper advantage, in violation of the FCPA, UKBA or any other applicable anti-corruption laws.
(b)(i) The operations of Borrower and its … advantage, in violation of the FCPA, UKBA or any other applicable anti-corruption laws, (ii) in violation of any Anti-Money Laundering Laws, or (iii
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
Obligations
Section 7.19
Products
Section 7.20
Anti-Corruption Laws.
Section 7.21
Data Privacy
ARTICLE 8
INDEMNIFICATION
Section 8.1
General … with the FCPA or any other applicable anti-bribery or anti-corruption law. To the Knowledge of the Seller, neither the Seller nor any of its Affiliates
8-K
EX-2.1
p1w3n8t8duqn552zv
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
j4aexw8rx4yv 03u
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
6g3opvjpk5kf6
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
jnis781sh1w3xt3
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
8-K
EX-1.1
gkamnifhb5 9tju7f7
18 May 23
Other Events
5:02pm
8-K
EX-10.1
9dwaavno
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am